Identification of Prostate Cancer Stage in Hispanics Using Serum Protein Profile

使用血清蛋白谱鉴定西班牙裔前列腺癌分期

• 批准号: 7933123
• 负责人: Margarita Irizarry-Ramirez
• 金额: $ 11万
• 依托单位: UNIVERSITY OF PUERTO RICO MED SCIENCES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7933123
• 关键词: Accounting; Address; Affect; African American; Asians; Biopsy; Blinded; Cancer Etiology; Cancer Patient; Caucasians; Caucasoid Race; Cessation of life; Characteristics; Chemistry; Clinical; Collaborations; Development; Diagnosis; Diagnostic; Diagnostic Neoplasm Staging; Disease; Disease Marker; Disease Progression; Early identification; Electrons; Epidemiologist; Epigenetic Process; Ethnic Origin; Event; Genetic; Goals; Hispanics; Knowledge; Lasers; Lead; Malignant neoplasm of prostate; Manuscripts; Mass Spectrum Analysis; Medical; Methodology; Molecular; Molecular Biology; National Cancer Institute; Newly Diagnosed; Not Hispanic or Latino; Outcome; Patients; Pattern; Peptides; Physiological; Physiology; Population; Positioning Attribute; Predictive Value; Preparation; Process; Prostate; Prostate-Specific Antigen; Protein Microchips; Proteins; Proteome; Proteomics; Puerto Rico; Research; Robotics; Role; Rosa; Sampling; Science; Screening procedure; Serum; Serum Proteins; Specificity; Staging; Surface; Survival Rate; System; Techniques; Testing; Time; Translating; Tumor Markers; United States; Universities; Urologist; Vermont; Veterans Hospitals; Work; base; cancer risk; computerized data processing; design; digital; disease characteristic; improved; instrument; male; mass spectrometer; men; molecular marker; mortality; neoplasm registry; patient population; protein expression; protein profiling; rectal; response; statistics; surface enhanced laser desorption ionization; tool; tumor progression

DESCRIPTION (provided by applicant): Prostate cancer is the second leading cause of cancer related death among males. The Hispanic population is affected by the disease, and their five year survival rates are lower when compared to the white non Hispanic population although somewhat better than for the African-American males. Current tumor markers in use in the clinical setting have been shown to have low specificity and positive predictive value. Recently some studies have suggested distinct protein patterns expressed in the serum of Caucasian and African-American and Asian prostate cancer patients. No study has been done in a population with a strong Hispanic inheritance. The long term goal is to identify molecular markers related to prostate cancer (Pac) progression in Hispanics and to their response to therapy. The objective of this study is to evaluate protein patterns of Pac in a Hispanic population. The central hypothesis is that prostate gland proteome expression, changes through progression stages of the disease, therefore the onset of distinct proteomic patterns may serve as a predictor of tumor progression in the prostate gland and help to explain the characteristics of Pac In this population. The methodology will incorporate the use of Surface Enhanced Laser Desorption lonization (SELDI-TOF) and protein electro focusing to compare the patterns of protein expression in healthy patients and in newly diagnosed untreated prostate cancer patients. Our first specific aim is to identify a protein pattern in the sera of newly diagnosed Hispanic prostate cancer patients in Puerto Rico. Since signature protein(s) that appear in these Hispanic patients and that are absent or not described in other populations, may account for the difference PCA characteristics in this population, our second aim is to select and characterize distinct protein(s) that may be crucial to the understanding of the underlying molecular mechanisms and physiological significance. Finally our third aim is to correlate protein patterns with progression of the disease and type of treatment, in the context of this project, results from these correlations may serve as the base for a broader study to find predictive markers to assign patients to specific therapies. The rationale for this work is that the identification of early markers of disease and of markers for cancer stage progression will eventually translate into better diagnosis and survival rate for the Hispanic population and that these markers may acquire generalizability. With the capability of characterizing the protein(s) that composes the different profiles, it will be possible to study their possible role in the physiology of the disease. This knowledge will significantly enhance the capacity to target these proteins for the development of new therapies or a better use of current therapies, thus improving survival.

描述（由申请人提供）：前列腺癌是男性癌症相关死亡的第二大原因。西班牙裔人口受到疾病的影响，与非西班牙裔的白色白人人口相比，他们的五年生存率较低，但略好于非洲裔美国男性。目前在临床环境中使用的肿瘤标志物已被证明具有低特异性和阳性预测值。最近的一些研究表明，不同的蛋白质模式表达在白人和非洲裔美国人和亚洲前列腺癌患者的血清中。没有研究已经在一个人口与一个强大的西班牙裔遗传。长期目标是确定与西班牙裔前列腺癌（Pac）进展及其对治疗反应相关的分子标志物。本研究的目的是评估西班牙裔人群中Pac的蛋白质模式。中心假设是前列腺蛋白质组表达在疾病的进展阶段发生变化，因此不同蛋白质组模式的发生可以作为前列腺肿瘤进展的预测因子，并有助于解释该人群中Pac的特征。该方法将结合使用表面增强激光解吸电离（SELDI-TOF）和蛋白质电聚焦，以比较健康患者和新诊断的未经治疗的前列腺癌患者的蛋白质表达模式。我们的第一个具体目标是确定一个蛋白质模式的新诊断的西班牙裔前列腺癌患者在波多黎各的血清中。由于签名蛋白出现在这些西班牙裔患者中，而在其他人群中不存在或未描述，可能解释了该人群中PCA特征的差异，因此我们的第二个目标是选择和表征可能对理解潜在分子机制和生理意义至关重要的不同蛋白。最后，我们的第三个目标是将蛋白质模式与疾病进展和治疗类型相关联，在本项目的背景下，这些相关性的结果可以作为更广泛研究的基础，以找到预测标记物，为患者分配特定治疗。这项工作的基本原理是，疾病的早期标志物和癌症阶段进展的标志物的鉴定将最终转化为西班牙裔人口的更好的诊断和生存率，这些标志物可能获得普遍性。随着表征组成不同谱的蛋白质的能力，将有可能研究它们在疾病生理学中的可能作用。这些知识将显著增强靶向这些蛋白质的能力，以开发新疗法或更好地利用现有疗法，从而提高生存率。